Price the GTM outcome, not the AI seat

Seats are easy to sell. Meetings are hard to fake.

TechCrunch reported Ema's $77M Series B with a pricing story built around task outcomes, not seats or tokens, plus a bookings narrative. Use that as a receipt. You do not need the round to change how you buy. Founders shopping AI GTM tools should buy pipeline outcomes, not chair count with a chatbot sticker.

If the vendor cannot price a meeting or a booked outcome, you are buying seat theater with a model attached.

What is outcome pricing in GTM tools?

Outcome pricing ties spend to a result you can put in a CRM: a qualified meeting, a completed workflow, a resolved task with a named definition.

Seat pricing ties spend to how many humans can log in. Token pricing ties spend to how loud the model gets. Both can be honest. Both also hide whether your CAC moved.

Grow-stage buyers should ask one question first: what unit of value are we paying for, and can finance audit it?

Why do seat and token deals inflate vanity?

Because the dashboard can look healthy while pipeline is dead.

You added 40 seats. Tokens spiked. "AI touches" went up. None of that is a meeting. Vanity metrics love seats. Boards clap for adoption. Cash cares about closed revenue and payback.

Salesforce's ~27% quota hit rate does not improve because your tool vendor sold you more logins. It improves when more of the ~5% in-market buyers (Ehrenberg-Bass / LinkedIn B2B Institute) take a real conversation.

Meetings, not theater is the filter. If the contract celebrates usage and your calendar is empty, you bought theater.

How should founders evaluate an AI GTM purchase?

Four checks before you sign.

1. Unit of outcome. Meeting booked, meeting held, opportunity created. Pick one. Write the definition.
2. Attribution window. Same-week signal to send to meeting, or 84-day Forrester-style fog? Prefer short, named windows.
3. Kill path. Can you pause spend when outcomes miss for two cycles? Outcome deals without a brake are still traps.
4. Spend share. What % of GTM budget does this tool eat vs meetings it creates? See evaluate AI tools by spend share.

If the vendor only offers per-seat and "you'll figure ROI later," you are the product.

What if I am the vendor pricing AI GTM?

Same knife, other side of the table.

Price the outcome you can defend. Bookings tied to defined tasks beat "unlimited AI seats" that train buyers to expect magic. Buyers who pay for outcomes ask sharper questions. That is good. Soft buyers on seat deals churn when tokens do not feel like pipeline.

Do not invent a metric. Use meetings, held rate, or opportunity create with a human QA sample. Autopilot "AI closed it" claims without disclosure belong in the trash. See the trust frame in Convert: honest mechanism, not costume.

How do I run a 30-day outcome pilot?

Pick one motion: signal-matched outbound or inbound hand-raiser follow-up.

Baseline: meetings held per week from that motion for the prior 30 days.

Pay (or track) against meetings held above baseline, with a clear fit filter. Cap volume. Require a human kill-switch on bounce and complaint.

At day 30: if meetings did not move and seats did, cancel. Do not renew because "the team likes the UI."

Would you rather a cheaper seat that never books, or a dearer outcome unit that fills the calendar with ICP?

You need 7 sales, not 7,000 AI touches.

Adapt or fail. Buy the meeting. Price the meeting. Kill the seat theater.

Start Signals, Convert, Grow

FAQ

Are seats always wrong?

No. Seats can be fine for collaboration tools. For AI GTM that claims pipeline impact, seats alone are a weak unit.

What if outcomes are hard to attribute?

Then start with held meetings from a named motion, not "influenced pipeline" poetry.

Should startups demand outcome pricing from every vendor?

Demand outcome measurement even when the invoice is seats. If they refuse any audit path, walk.

How does this tie to Signals → Convert → Grow?

Signals create the chance. Convert earns the meeting. Grow spends on tools that buy more of that meeting, not more logins.

Is token pricing better than seats?

Only if tokens map to a defined task you care about. Raw tokens are still vanity without an outcome definition.